David Cameron Pryde

USPTO Granted Patents = 12 (Patent Applications = 8)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 190(Granted Patents)

Location History:

Walmer, GB (2015)
Great Abington, GB (2015 - 2020)
Sandwich, GB (2003 - 2023)

Company Filing History:

Curadev Pharma Private Limited

patents

Years Active: 2003-2023

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11571423 - Small molecule modulators of human sting (2023-02-07),

2. 10538523 - 4-(biphen-3-yl)-1H-pyrazolo[3,4-c]pyridazine derivatives of formula (I) as GABA receptor modulators for use in the treatment of epilepsy and pain (2020-01-21),

3. 9802945 - Imidazopyridazine derivatives as modulators of the GABAA receptor activity (2017-10-31),

4. 9216229 - IgE CH3 peptide vaccine (2015-12-22),

5. 8980276 - Conjugates for the prevention or treatment of nicotine addiction (2015-03-17),

6. 8952008 - Chemical compounds (2015-02-10),

7. 8475801 - IgE CH3 peptide vaccine (2013-07-02),

8. 8298547 - IgE CH3 peptide vaccine (2012-10-30),

9. 7691877 - Pharmaceuticals (2010-04-06),

10. 7642350 - Purine derivatives (2010-01-05),

11. 6849649 - N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase (2005-02-01),

12. 6660756 - N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase (2003-12-09),

Title: David Cameron Pryde: Innovator Extraordinaire

Introduction:

David Cameron Pryde, a visionary inventor hailing from Sandwich, GB, has left an indelible mark on the world of technology with his groundbreaking inventions. His relentless pursuit of innovation has led to the creation of numerous patented technologies, shaping the landscape of modern healthcare.

Latest Patents:

David Cameron Pryde's latest patents showcase his ingenuity and commitment to advancing medical science. His inventions include small molecule modulators of the human STING protein for treating cancer and microbial infections, as well as GABA receptor modulators for the treatment of epilepsy and pain.

Career Highlights:

With an impressive portfolio of 12 patents to his name, David Cameron Pryde has been a pivotal figure in the field of medical research. His work at Pfizer Corporation and Pfizer Vaccines, LCC, has been instrumental in developing cutting-edge pharmaceutical solutions that have the potential to revolutionize healthcare.

Collaborations:

Throughout his illustrious career, David Cameron Pryde has collaborated with esteemed colleagues such as Alan Daniel Brown and Lyn Howard Jones. Together, they have contributed to the advancement of medical science and the development of novel treatment options for a wide range of conditions.

Conclusion:

In conclusion, David Cameron Pryde stands as a beacon of innovation, with his inventive spirit and relentless drive propelling him to the forefront of the technological landscape. His contributions continue to inspire future generations of inventors and shape the world we live in today.

This text is generated by artificial intelligence and may not be accurate.